BF
Therapeutic Areas
Cogent Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Bezuclastinib | NonAdvanced Systemic Mastocytosis (NonAdvSM) | NDA Submitted |
| Pre-clinical programs | Various genetically defined diseases | Pre-clinical |
Leadership Team at Cogent Biosciences
AR
Andrew Robbins
Chief Executive Officer and President
JS
Jessica Sachs
Chief Medical Officer
CP
Cole Pinnow
Chief Commercial Officer
JR
John Robinson
Chief Scientific Officer
BB
Brad Barnett
Chief Technology Officer
ES
Erin Schellhammer
Chief People Officer
EK
Evan Kearns
Chief Legal Officer and Corporate Secretary
JG
John Green
Chief Financial Officer
FS
Francis Sullivan
Senior Vice President, Enzymology & Structural Biology
SW
Shannon Winski
Senior Vice President, Translational Science